Mounjaro Weight Loss in Nansana

Mounjaro (active ingredient Tirzepatide) is an FDA-approved injectable medication that targets both GIP and GLP-1 receptors. It reduces appetite, slows digestion, and regulates blood sugar, enabling consistent calorie deficit and weight loss.

Clinical studies show that patients can lose up to 15% to 20% or more of their total body weight over several months when combined with diet and lifestyle modifications supervised by our clinical specialists.

Mounjaro is administered once a week as a tiny subcutaneous injection under the skin (abdomen, thigh, or upper arm). Our medical staff provides hands-on guidance for effortless self-administration or in-clinic doses.

Ideal candidates include adults with a BMI of 30 or higher (or 27+ with weight-related conditions like high blood pressure or insulin resistance) who have struggled to lose weight through exercise and diet alone.

Mild side effects may include mild nausea, constipation, or indigestion, particularly when starting or increasing doses. These usually subside as your body adjusts, and our doctors manage dose titration to minimize discomfort.

Treatment duration depends on your individual weight loss goals and medical progress. Many patients undergo an active weight loss phase followed by a maintenance phase structured by our clinical team.

Yes! Combining Mounjaro with our nutritionist counseling and body contouring therapies (like Cryolipolysis or EM Body Sculpt) maximizes fat loss while retaining lean muscle and toning skin.

Treatment costs depend on prescribed dosage levels, protocol duration, and required medical oversight. An initial consultation allows our medical team to outline a customized plan with precise pricing.